Cargando…
Sub-MIC streptomycin and tetracycline enhanced Staphylococcus aureus Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics
Staphylococcus aureus is a major human pathogen, a potential “Super-bug” and a typical biofilm forming bacteria. With usage of large amount of antibiotics, the residual antibiotics in clinical settings further complicate the colonization, pathogenesis and resistance of S. aureus. This study aimed at...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539642/ https://www.ncbi.nlm.nih.gov/pubmed/37779859 http://dx.doi.org/10.1016/j.bioflm.2023.100156 |
_version_ | 1785113545653878784 |
---|---|
author | Liu, Junyan Huang, Tengyi Xu, Zhenbo Mao, Yuzhu Soteyome, Thanapop Liu, Gongliang Qu, Chunyun Yuan, Lei Ma, Qin Zhou, Fang Seneviratne, Gamini |
author_facet | Liu, Junyan Huang, Tengyi Xu, Zhenbo Mao, Yuzhu Soteyome, Thanapop Liu, Gongliang Qu, Chunyun Yuan, Lei Ma, Qin Zhou, Fang Seneviratne, Gamini |
author_sort | Liu, Junyan |
collection | PubMed |
description | Staphylococcus aureus is a major human pathogen, a potential “Super-bug” and a typical biofilm forming bacteria. With usage of large amount of antibiotics, the residual antibiotics in clinical settings further complicate the colonization, pathogenesis and resistance of S. aureus. This study aimed at investigating the phenotypical and global gene expression changes on biofilm formation of a clinical S. aureus isolate treated under different types of antibiotics. Firstly, an isolate Guangzhou-SAU749 was selected from a large sale of previously identified S. aureus isolates, which exhibited weak biofilm formation in terms of biomass and viability. Secondly, 9 commonly prescribed antibiotics for S. aureus infections treatment, together with 10 concentrations ranging from 1/128 to 4 minimum inhibitory concentration (MIC) with 2-fold serial dilution, were used as different antibiotic stress conditions. Then, biofilm formation of S. aureus Guangzhou-SAU749 at different stages including 8 h, 16 h, 24 h, and 48 h, was tested by crystal violet and MTS assays. Thirdly, the whole genome of S. aureus Guangzhou-SAU749 was investigated by genome sequencing on PacBio platform. Fourthly, since enhancement of biofilm formation occurred when treated with 1/2 MIC tetracycline (TCY) and 1/4 MIC streptomycin (STR) since 5 h, the relevant biofilm samples were selected and subjected to RNA-seq and bioinformatics analysis. Last, expression of two component system (TCS) and biofilm associated genes in 4 h, 8 h, 16 h, 24 h, and 48 h sub-MIC TCY and STR treated biofilm samples were performed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Although most antibiotics lowered the biomass and cell viability of Guangzhou-SAU749 biofilm at concentrations higher than MIC, certain antibiotics including TCY and STR promoted biofilm formation at sub-MICs. Additionally, upon genome sequencing, RNA-seq and RT-qPCR on biofilm samples treated with sub-MIC of TCY and STR at key time points, genes lytR, arlR, hssR, tagA, clfB, atlA and cidA related to TCS and biofilm formation were identified to contribute to the enhanced biofilm formation, providing a theoretical basis for further controlling on S. aureus biofilm formation. |
format | Online Article Text |
id | pubmed-10539642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105396422023-09-30 Sub-MIC streptomycin and tetracycline enhanced Staphylococcus aureus Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics Liu, Junyan Huang, Tengyi Xu, Zhenbo Mao, Yuzhu Soteyome, Thanapop Liu, Gongliang Qu, Chunyun Yuan, Lei Ma, Qin Zhou, Fang Seneviratne, Gamini Biofilm Article Staphylococcus aureus is a major human pathogen, a potential “Super-bug” and a typical biofilm forming bacteria. With usage of large amount of antibiotics, the residual antibiotics in clinical settings further complicate the colonization, pathogenesis and resistance of S. aureus. This study aimed at investigating the phenotypical and global gene expression changes on biofilm formation of a clinical S. aureus isolate treated under different types of antibiotics. Firstly, an isolate Guangzhou-SAU749 was selected from a large sale of previously identified S. aureus isolates, which exhibited weak biofilm formation in terms of biomass and viability. Secondly, 9 commonly prescribed antibiotics for S. aureus infections treatment, together with 10 concentrations ranging from 1/128 to 4 minimum inhibitory concentration (MIC) with 2-fold serial dilution, were used as different antibiotic stress conditions. Then, biofilm formation of S. aureus Guangzhou-SAU749 at different stages including 8 h, 16 h, 24 h, and 48 h, was tested by crystal violet and MTS assays. Thirdly, the whole genome of S. aureus Guangzhou-SAU749 was investigated by genome sequencing on PacBio platform. Fourthly, since enhancement of biofilm formation occurred when treated with 1/2 MIC tetracycline (TCY) and 1/4 MIC streptomycin (STR) since 5 h, the relevant biofilm samples were selected and subjected to RNA-seq and bioinformatics analysis. Last, expression of two component system (TCS) and biofilm associated genes in 4 h, 8 h, 16 h, 24 h, and 48 h sub-MIC TCY and STR treated biofilm samples were performed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Although most antibiotics lowered the biomass and cell viability of Guangzhou-SAU749 biofilm at concentrations higher than MIC, certain antibiotics including TCY and STR promoted biofilm formation at sub-MICs. Additionally, upon genome sequencing, RNA-seq and RT-qPCR on biofilm samples treated with sub-MIC of TCY and STR at key time points, genes lytR, arlR, hssR, tagA, clfB, atlA and cidA related to TCS and biofilm formation were identified to contribute to the enhanced biofilm formation, providing a theoretical basis for further controlling on S. aureus biofilm formation. Elsevier 2023-09-20 /pmc/articles/PMC10539642/ /pubmed/37779859 http://dx.doi.org/10.1016/j.bioflm.2023.100156 Text en © 2023 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Liu, Junyan Huang, Tengyi Xu, Zhenbo Mao, Yuzhu Soteyome, Thanapop Liu, Gongliang Qu, Chunyun Yuan, Lei Ma, Qin Zhou, Fang Seneviratne, Gamini Sub-MIC streptomycin and tetracycline enhanced Staphylococcus aureus Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics |
title | Sub-MIC streptomycin and tetracycline enhanced Staphylococcus aureus Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics |
title_full | Sub-MIC streptomycin and tetracycline enhanced Staphylococcus aureus Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics |
title_fullStr | Sub-MIC streptomycin and tetracycline enhanced Staphylococcus aureus Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics |
title_full_unstemmed | Sub-MIC streptomycin and tetracycline enhanced Staphylococcus aureus Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics |
title_short | Sub-MIC streptomycin and tetracycline enhanced Staphylococcus aureus Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics |
title_sort | sub-mic streptomycin and tetracycline enhanced staphylococcus aureus guangzhou-sau749 biofilm formation, an in-depth study on transcriptomics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539642/ https://www.ncbi.nlm.nih.gov/pubmed/37779859 http://dx.doi.org/10.1016/j.bioflm.2023.100156 |
work_keys_str_mv | AT liujunyan submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT huangtengyi submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT xuzhenbo submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT maoyuzhu submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT soteyomethanapop submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT liugongliang submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT quchunyun submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT yuanlei submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT maqin submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT zhoufang submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics AT seneviratnegamini submicstreptomycinandtetracyclineenhancedstaphylococcusaureusguangzhousau749biofilmformationanindepthstudyontranscriptomics |